Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial The Lancet Oncology - Tập 15 Số 8 - Trang 799-808 - 2014
Bradley J. Monk, Andrés Poveda, Ignace Vergote, Francesco Raspagliesi, Keiichi Fujiwara, Duk‐Soo Bae, Ana Oaknin, Isabelle Ray‐Coquard, Diane Provencher, Beth Y. Karlan, Catherine Lhommé, Gary Richardson, Dolores Gallardo Rincón, Robert L. Coleman, Thomas J. Herzog, Christian Marth, Arija Brize, Michel Fabbro, Andrés Redondo, Aristotelis Bamias, Marjan Tassoudji, Lynn Navale, Douglas Warner, Amit M. Oza
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial The Lancet Oncology - Tập 15 Số 11 - Trang 1269-1278 - 2014
Gϋnter von Minckwitz, Fabio Puglisi, Javier Cortés, Eduard Vrdoljak, Norbert Marschner, Christoph Zielinski, Cristian Villanueva, Gilles Romieu, István Láng, Eva Ciruelos, Michelino De Laurentiis, Corinne Veyret, Sabine de Ducla, Ulrich Freudensprung, Stefanie Srock, Joseph Gligorov
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial The Lancet Oncology - Tập 16 Số 8 - Trang 928-936 - 2015
Amit M. Oza, Adrian Cook, Jacobus Pfisterer, Andrew Embleton-Thirsk, Jonathan A. Ledermann, Éric Pujade-Lauraine, Gunnar B. Kristensen, Mark S. Carey, Philip Beale, Andrés Cervantes, Tjoung‐Won Park‐Simon, Gordon Rustin, Florence Joly, Mansoor Raza Mirza, Marie Plante, Michael Quinn, Andrés Poveda, Gordon C. Jayson, Dan Stark, Ann Marie Swart, Laura Farrelly, Richard Kaplan, Mahesh Parmar, Timothy Perren
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial The Lancet Oncology - Tập 14 Số 10 - Trang 933-942 - 2013
David Cameron, Julia Brown, Rebecca Dent, Christian Jackisch, John R. Mackey, Xavier Pivot, Guenther G. Steger, Thomas Suter, Masakazu Toi, Mahesh Parmar, R. Laeufle, Young‐Hyuck Im, Gilles Romieu, Vernon Harvey, Oleg Lipatov, Tadeusz Pieńkowski, Paul Cottu, Arlene Chan, Seock‐Ah Im, Peter Hall, Lida Bubuteishvili‐Pacaud, Volkmar Henschel, Regula Deurloo, Céline Pallaud, Richard H. Bell
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial The Lancet Oncology - Tập 14 Số 10 - Trang 1020-1026 - 2013
Noriyuki Katsumata, Makoto Yasuda, Seiji Isonishi, Fumiaki Takahashi, Hirofumi Michimae, Eizo Kimura, Daisuke Aoki, Toshiko Jobo, Shoji Kodama, Fumitoshi Terauchi, Toru Sugiyama, Kazunori Ochiai
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial The Lancet Oncology - Tập 13 Số 10 - Trang 1045-1054 - 2012
Penella J. Woll, Peter Reichardt, Axel Le Cesne, Sylvie Bonvalot, Alberto Azzarelli, Harald J. Hoekstra, Michael Leahy, Frits van Coevorden, Jaap Verweij, Pancras C.W. Hogendoorn, M. Ouali, Sandrine Marréaud, Vivien Bramwell, Peter Hohenberger
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study The Lancet Oncology - Tập 15 - Trang 1207-1214 - 2014
Joyce F Liu, William T Barry, Michael Birrer, Jung-Min Lee, Ronald J Buckanovich, Gini F Fleming, BJ Rimel, Mary K Buss, Sreenivasa Nattam, Jean Hurteau, Weixiu Luo, Philippa Quy, Christin Whalen, Lisa Obermayer, Hang Lee, Eric P Winer, Elise C Kohn, S Percy Ivy, Ursula A Matulonis
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial The Lancet Oncology - Tập 23 - Trang 540-552 - 2022
Hedy L Kindler, Silvia Novello, Alessandra Bearz, Giovanni L Ceresoli, Joachim G J V Aerts, James Spicer, Paul Taylor, Kristiaan Nackaerts, Alastair Greystoke, Ross Jennens, Luana Calabrò, Jacobus A Burgers, Armando Santoro, Susana Cedrés, Piotr Serwatowski, Santiago Ponce, Jan P Van Meerbeeck, Anna K Nowak, George Blumenschein, Jonathan M Siegel
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial The Lancet Oncology - Tập 18 Số 9 - Trang 1261-1273 - 2017
Michele Maio, Arnaud Scherpereel, Luana Calabrò, Joachim G.J.V. Aerts, S. Cedrés, Alessandra Bearz, Kristiaan Nackaerts, Dean A. Fennell, Dariusz Kowalski, Anne S. Tsao, Paul Taylor, Federica Grosso, Scott Antonia, Anna K. Nowak, Maria Taboada, M. Puglisi, Paul K. Stockman, Hedy L. Kindler
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study The Lancet Oncology - Tập 12 Số 8 - Trang 763-772 - 2011
Tom Treasure, Loı̈c Lang-Lazdunski, David Waller, Judith M. Bliss, Carol Tan, James Entwisle, M. Snee, Mary Claire O’Brien, Gill Thomas, Suresh Senan, Kenneth J. O’Byrne, Lucy Kilburn, James Spicer, David Landau, John Edwards, Gill Coombes, Liz Darlison, Julian Peto
